Phillips-Medisize, a Molex company, is a leading global outsource provider of design development and manufacturing services to the medical (medical device, diagnostics, and drug delivery products) and commercial (automotive, consumer, and defense) markets. 85% of the company's total revenue comes from drug delivery, medical device, primary pharmaceutical packaging and diagnostic products.
Phillips-Medisize partners with customers, providing design and development services that accelerate speed to market of innovation products. The company then works with its customers to deploy advanced automated assembly and quality control technologies which reduce manufacturing cost while improving quality. The company's core advantage is the knowledge of its people to integrate design, molding, and automation to drive low cost and high quality manufacturing solutions.
Phillips-Medisize facilities are FDA registered for clean-room molding, medical device assembly, drug handling and packaging, sterilization management, and final device packaging under ISO 9001, ISO 14001, ISO 13485, FDA 21CFR 820, FDA 21CFR 210/211.
Phillips-Medisize is an Affirmative Action/Equal Opportunity/Disability/Protected Veteran employer.